Stocks
Heron Therapeutics (HRTX) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 4.90% | 7.69% | 3.50% | 1.69% | 1.22% | 1.23% | |||
| Changes by years, y/y, % | -7pp | +3pp | -4pp | -2pp | 0pp | -36.6% | |||
Heron Therapeutics. CAPEX/Revenue, %
Heron Therapeutics. CAPEX/Revenue, changes, pp
Heron Therapeutics (HRTX) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| CAPEX/Revenue, % | 0.88% | 2.52% | 0.73% | 0.00% | 1.77% | 1.23% | ||
| Changes by years, y/y, % | 0pp | +2pp | -1pp | -1pp | +1pp | |||
| Changes by quarters, q/q, % | +0pp | +2pp | -2pp | -1pp | ||||
